Skip to content
Business Company News, Medical Health Aged Care

Entrepreneur and athlete backed start-up UAre seeks $1 Million to revolutionise longevity and well-being

Chapter One Advisors 2 mins read

UAre, the innovative longevity business founded by experienced entrepreneurs Marc Pasques, Grant Ellison, and Kendrick Louis, has launched a $1 million seed funding round (post raise valuation of $9 million), with funds to be applied to enabling UAre to scale its unique solution designed to measure and maximise quality of life and longevity for individuals and organisations.


Innovative Approach to Longevity


UAre consolidates data from the UAre app and various wearable technologies, then standardises it for users, providing insightful data on movement, mindset, relationships, and habits. By leveraging this data, UAre offers personalised recommendations and an estimated life expectancy, helping users make informed decisions to enhance their well-being and longevity.


B2B Offering: Enhancing Organisational Performance


UAre’s solution is not just for individuals; it also offers significant benefits for organisations. The company provides anonymised aggregated insights that enable businesses to ethically benchmark and improve the performance and longevity of their employees, customers, and members. This ensures that companies can accurately target and maximise their return on investment in human capital. UAre’s premium service bundles for B2B customers include mentoring from elite athletes and epigenetic testing, providing a comprehensive approach to enhancing employee well-being and productivity.


“We’re providing businesses with critical insights into their wellbeing programs' effectiveness, guiding them on where to invest next,” said Kendrick Louis. “This seed raise is a significant milestone in our journey to make a meaningful impact on global health and longevity.”


Meet the Founders

  • Grant Ellison, a successful entrepreneur, and strategist. Has founded and led multi-national tech businesses through start-up, scale-up, IPO and exit. For more info see:


  • Marc Pasques is an experienced customer focused tech leader. Expert in building and managing teams to deliver scalable solutions for multi-national businesses. For more info see:



A Growing Market


The wearable technology market is expanding rapidly. A recent study by Telsyte revealed that 36% of Australians now own a smartwatch, with the market projected to reach $5.3 billion this year and potentially grow to $6.5 billion by 2029​​. UAre’s innovative approach positions it at the forefront of this growth, offering unique solutions that cater to both individual and organisational needs.


Future Prospects


“We’re bullish on UAre’s future,” said Grant Ellison. “We forecast a revenue of $30 million by the end of 2026 and an enterprise valuation of $150 million. Our goal is to have 500,000 users and 200 businesses signed up for our application.”


By the end of 2024, UAre anticipates having 30 business customers and 50,000 individual members, generating about $1 million in revenue. Growth is expected to be driven by uptake from businesses and investments in premium services such as mentoring from elite athletes and epigenetic testing.


About UAre


UAre is a pioneering company dedicated to enhancing longevity and well-being through advanced technology and personalised insights. By integrating data from wearable devices and offering tailored recommendations, UAre empowers individuals and organizations to improve their quality of life and achieve their wellness goals.

Contact details:

Kendrick Louis
Co-Founder, UAre


More from this category

  • Community, Medical Health Aged Care
  • 22/07/2024
  • 17:24
Odyssey Lifestyle Care Communities

Dancing and dining; seniors celebrate four fabulous years

Odyssey Lifestyle Care Communities recently celebrated a significant milestone in style, marking its fourth birthday with an evening full of fun, fantastic food and…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 22/07/2024
  • 12:56

Research into psychedelic medicines to treat anxiety wins ANS Illumina Neurogenomics Award 2024

Genomic technologies to discover biological markers, within the blood, that could predict patient response to psychedelic medicines such as psilocybin. MELBOURNE, AUSTRALIA, 22 July 2024 - Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the winner of the annual Australasian Neuroscience Society (ANS) Illumina Neurogenomics Research Award as Dr Andrew Gibbons from the Department of Psychiatry, School of Clinical Sciences at Monash Health. “Psilocybin, a chemical produced by hallucinogenic mushrooms, is a psychedelic medicine that has shown to meaningfully reduce symptoms of generalized anxiety during psychotherapy for patients. However, not all patients respond.…

  • Contains:
  • Industrial Relations, Medical Health Aged Care
  • 22/07/2024
  • 11:12
Australian Nursing and Midwifery Federation (Victorian Branch)

Bolton Clarke nurses and carers to hold stop-work rally – Mon 22 July, 1pm-2pm

WHATANMF Bolton Clarke members two-hour stop work and community rally for fair pay and conditionsACTU Secretary Sally McManus and VTHC Secretary Luke Hilakari will address the rally WHENMonday, 22 July 2024, 1pm-3pm. (Speakers will start 1.05pm sharp) WHEREoutside Bolton Clarke’s Victorian headquarters, 347 Burwood Highway, Forest Hill Bolton Clarke nurses, personal care workers and midwives will stop work for two hours on Monday 22 July to rally for better pay and conditions. For the past 18 months, the Australian Nursing and Midwifery Federation (Victorian Branch) has been negotiating wages and conditions on behalf of about 1700 members working across Bolton…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.